John Chalmers
Directeur/Membre du Conseil chez Prognomix, Inc.
Profil
John Chalmers is currently a Director at Prognomix, Inc. He previously held positions as Chairman & President at National Health & Medical Research Council and International Society of Hypertension, Principal at Royal Prince Alfred Hospital and Massachusetts Institute of Technology.
He received a doctorate degree from The University of New South Wales in 1967 and an undergraduate degree from The University of Sydney in 1963.
Postes actifs de John Chalmers
Sociétés | Poste | Début |
---|---|---|
Prognomix, Inc.
Prognomix, Inc. Pharmaceuticals: GenericHealth Technology Prognomix, Inc. develops market molecular diagnostic kits for testing of diabetes complications. Its products include PGX IR01, PGx GR01, PGx CD01 and PGx IR02. The firm focuses on discovery and clinical application of genomic signatures predictive of susceptibility to diseases, their complications and individual therapeutic responsiveness. The company was founded by Johanne Tremblay and Pavel Hamet in 2005 and is headquartered in Montreal, Canada. | Directeur/Membre du Conseil | - |
Anciens postes connus de John Chalmers
Sociétés | Poste | Fin |
---|---|---|
International Society of Hypertension
International Society of Hypertension Miscellaneous Commercial ServicesCommercial Services The International Society of Hypertension (ISH) was established in 1966 and is committed to promoting and encouraging the advancement of hypertension research. The non-profit company is based in Hampton Hill, UK. The ISH Women in Hypertension Research Committee focuses on improving care for women with hypertension worldwide. Professor Bryan Williams has been announced as the next President of the ISH for the years 2022-2024. | Président | - |
Royal Prince Alfred Hospital
Royal Prince Alfred Hospital Hospital/Nursing ManagementHealth Services Royal Prince Alfred Hospital provides general medical and surgical services. The company was founded in 1882 and is headquartered in Sydney, Australia. | Corporate Officer/Principal | - |
National Health & Medical Research Council | Président | - |
Massachusetts Institute of Technology | Corporate Officer/Principal | - |
Formation de John Chalmers
The University of Sydney | Undergraduate Degree |
The University of New South Wales | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 4 |
---|---|
Prognomix, Inc.
Prognomix, Inc. Pharmaceuticals: GenericHealth Technology Prognomix, Inc. develops market molecular diagnostic kits for testing of diabetes complications. Its products include PGX IR01, PGx GR01, PGx CD01 and PGx IR02. The firm focuses on discovery and clinical application of genomic signatures predictive of susceptibility to diseases, their complications and individual therapeutic responsiveness. The company was founded by Johanne Tremblay and Pavel Hamet in 2005 and is headquartered in Montreal, Canada. | Health Technology |
Royal Prince Alfred Hospital
Royal Prince Alfred Hospital Hospital/Nursing ManagementHealth Services Royal Prince Alfred Hospital provides general medical and surgical services. The company was founded in 1882 and is headquartered in Sydney, Australia. | Health Services |
National Health & Medical Research Council | Government |
International Society of Hypertension
International Society of Hypertension Miscellaneous Commercial ServicesCommercial Services The International Society of Hypertension (ISH) was established in 1966 and is committed to promoting and encouraging the advancement of hypertension research. The non-profit company is based in Hampton Hill, UK. The ISH Women in Hypertension Research Committee focuses on improving care for women with hypertension worldwide. Professor Bryan Williams has been announced as the next President of the ISH for the years 2022-2024. | Commercial Services |